U.S. Monoclonal Antibody Cancer Therapeutics Market

Published by: Frost & Sullivan

Published: Feb. 1, 2001

Table of Contents

• Introducing the Market Engineering Consulting Report
  
  
  
  • Overview
    
  
  
• Executive Summary
  
  
  
  • Introduction to the US Monoclonal Antibody Cancer Therapeutics Market
    
  • Summary of Major Findings
    
  • Analysis of Market Engineering Research
    
  
  
• Market Engineering Research Methodology
  
  
  
  • Research Scope
    
  • Research Methodology
    
  • Market EngineeringForecasting Methodology
    
  • Glossary of Terms
    
  
  
• Industry Challenges
  
  
  
  • Identification of ChallengesFacing the Monoclonal AntibodyCancer Therapeutics Market
    
  
  
• Total U.S. Monoclonal Antibody Cancer Therapeutics Market 1996-2006
  
  
  
  • Market Overview
    
  • Scope/Segmentation
    
  • Market EngineeringResearch Measurement System
    
  • Monoclonal Antibodiesas Cancer Therapeutics
    
  • Market EngineeringRevenue Forecasts (1997-2006)
    
  
  
• Market Engineering Research for theU.S. Monoclonal Antibody Solid Tumor Therapeutics Market 1999-2006
  
  
  
  • Market Overview and Definitions
    
  • Market EngineeringResearch Measurement System
    
  • Market EngineeringRevenue Forecasts (1999-2006)
    
  • Competitive Analysis
    
  
  
• Market Engineering Research for the U.S. Monoclonal Antibody Anti-Angiogenesis Market 1999-2006
  
  
  
  • Market Overview and Definitions
    
  • Market Engineering Research Measurement System
    
  • Competitive Analysis
    
  
  
• Market Engineering Research for the U.S. Monoclonal Antibody Market for Leukemias and Lymphomas 1999-2006
  
  
  
  • Market Overview and Definitions
    
  • Scope and Segmentation
    
  • Market EngineeringResearch Measurement System
    
  • Market Engineering Revenue Forecasts (1999-2006)
    
  • Market EngineeringRevenue Forecasts (1999-2006)
    
  • Market EngineeringRevenue Forecasts (1999-2006)
    
  • Lymphoma
    
  
  
• Market Engineering Strategy
  
  
  
  • What Is Market Engineering Strategy?
    
  • Market Engineering Strategic Recommendations
    
  
  
• Market Engineering Planning
  
  
  
  • Integrating Market Engineering into the Business Planning Process
    
  
  
• Implementation of Market Engineering
  
  
  
  • How to Implement Market Engineering in a Company
    
  
  
• Market Engineering Monitoring of the U.S. Monoclonal Antibody Cancer Therapeutics Market
  
  
  
  • Purpose of Market Engineering Monitoring
    
  
  
• Market Engineering Awardsfor the Monoclonal Antibody Cancer Therapeutics Market
  
  
  
  • Frost & Sullivan's 2001 Market Engineering Awards
    
  • Market Engineering Awards
    
  
  
• Database of Key Industry Participants
  
  
  
  • Market Participants
    
  • Related Companies
    
  • Associations
    
  
  
• Market Engineering Supplement
  
  
  
  • Introduction
    
  • Strategic Significance of the Market Engineering Measurements
    
  • How to Improve the Market Engineering Strategy Development Process
    
  • How to Implement Market Engineering in a Company
    
  • How to Make the Most of ThisMarket Engineering Report
    
  • How to Design a SuccessfulMonitoring Program
    
  • Top Ten Critical Elements of aMarket Engineering Program
    
  • Strategic Recommendations forFurther Research
    
  
  

Abstract

Pharmaceutical and biotechnology companies are investing billions of dollars into research and development, trying to capture a share of the unlimited opportunities offered by the cancer therapeutics market. Monoclonal antibody (MAB)cancer therapeutics are considered to be one of the most promising cancer therapies in development. Financial experts already regard this emerging market as an industry with multi-billion-dollar potential.

Exciting research from Frost &Sullivan evaluates the current state of the U.S. monoclonal antibody cancer therapeutic markets and its three major segments: antibodies for solid tumors, anti-angiogenesis, and leukemias and lymphomas. Frost &Sullivan anticipates up to five new products entering the market within the next several years, propelling the U.S. monoclonal antibody cancer therapeutic market to new heights.

Partnerships Spark Increased Profit Margins

The average cost of developing a drug is $500 million. Since most of the companies competing in the U.S. monoclonal antibody cancer therapeutics market are small biotechnology, biopharmaceutical or pharmaceutical companies, they lack the monetary resources to bring their drugs to market. Partnerships with larger pharmaceutical houses are imperative to acquire the necessary sales and marketing support.

"Smaller market participants will need to manage the rising operating expenses through the establishment of partnerships with larger pharmaceutical companies," states the author of this research. "However, these companies are challenged to obtain sufficient clinical trial results before engaging in partnership agreements, in order to retain a significant direct share of future product revenues."

Clinical Results Must Support Companies 'Claims of Better Efficacy

Current cancer treatments, including surgery, chemotherapy, hormonal and radiation therapy are effective but using them in conjunction with MAB therapeutics may improve patients 'quality of life with fewer side effects. With more than 350 different cancer products in development, manufacturers of MAB therapeutics must prove, through extensive clinical research, that using these products increases the chances of survival in battling cancer. "MAB are highly specific and thus have fewer side effects and can be developed quicker," states the author of this report. "The extent of market acceptance of MAB therapies depends on manufacturers 'ability to demonstrate efficacy, safety, dosing, or scheduling advantages over these other products in development."

This Frost &Sullivan research concentrates on the present and future MAB therapies for cancer treatment. By providing market participants with the lat- est information, this report can help your company fully evaluate the market 's potential and make informed market decisions.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.